REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,094.00
Bid: 12,092.00
Ask: 12,094.00
Change: 44.00 (0.37%)
Spread: 2.00 (0.017%)
Open: 11,966.00
High: 12,162.00
Low: 11,966.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: JPMorgan Raises Man Group And Sanne

Thu, 10th Dec 2020 10:16

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

----------

FTSE 100

----------

BERENBERG RAISES CRODA INTERNATIONAL TO 'BUY' ('HOLD') - TARGET 7,200 (6,000) PENCE

----------

MORGAN STANLEY CUTS AVAST PRICE TARGET TO 610 (650) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY RAISES VODAFONE PRICE TARGET TO 205 (200) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY RAISES RIO TINTO PRICE TARGET TO 5,200 (4,290) PENCE - 'EQUAL-WEIGHT'

----------

MORGAN STANLEY RAISES GLENCORE PRICE TARGET TO 274 (215) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY RAISES EVRAZ PRICE TARGET TO 430 (410) PENCE - 'EQUAL-WEIGHT'

----------

MORGAN STANLEY RAISES BHP GROUP PRICE TARGET TO 1,960 (1,680) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY RAISES ANTOFAGASTA TARGET TO 1,305 (1,030) PENCE - 'EQUAL-WEIGHT'

----------

MORGAN STANLEY RAISES ANGLO AMERICAN TARGET TO 2,780 (2,280) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY RAISES SAGE GROUP TO 'EQUAL-WEIGHT' ('UNDERWEIGHT') - TARGET 610 PENCE

----------

JPMORGAN RAISES DS SMITH PRICE TARGET TO 408 (340) PENCE - 'OVERWEIGHT'

----------

DEUTSCHE BANK RAISES ASHTEAD GROUP PRICE TARGET TO 3,000 (2,150) PENCE - 'HOLD'

----------

BERENBERG RAISES POLYMETAL PRICE TARGET TO 2,580 (2,560) PENCE - 'BUY'

----------

GOLDMAN SACHS RAISES RIO TINTO PRICE TARGET TO 5,645 (4,685) PENCE - 'NEUTRAL'

----------

GOLDMAN RAISES BHP GROUP PRICE TARGET TO 2,360 (2,020) PENCE - 'BUY'

----------

JPMORGAN RAISES STANDARD LIFE ABERDEEN TARGET TO 315 (270) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES SCHRODERS PRICE TARGET TO 3,175 (2,800) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES INTERMEDIATE CAPITAL TARGET TO 2,000 (1,950) PENCE - 'OVERWEIGHT'

----------

JPMORGAN CUTS HARGREAVES LANSDOWN TARGET TO 1,390 (1,470) PENCE - 'UNDERWEIGHT'

----------

JPMORGAN CUTS BUNZL TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 2,800 PENCE

----------

JEFFERIES RAISES ASTRAZENECA PRICE TARGET TO 8,500 (8,100) PENCE - 'HOLD'

----------

FTSE 250

----------

JPMORGAN RAISES SANNE GROUP TO 'OVERWEIGHT' ('NEUTRAL') - TARGET 670 PENCE

----------

JPMORGAN RAISES MAN GROUP TO 'OVERWEIGHT' ('NEUTRAL') - TARGET 150 (140) PENCE

----------

UBS RAISES VICTREX PRICE TARGET TO 1,750 (1,625) PENCE - 'SELL'

----------

MORGAN STANLEY CUTS CENTAMIN PRICE TARGET TO 125 (130) PENCE - 'EQUAL-WEIGHT'

----------

JPMORGAN RAISES INCHCAPE PRICE TARGET TO 708 (645) PENCE - 'OVERWEIGHT'

----------

BERENBERG CUTS WORKSPACE GROUP TO 'SELL' ('HOLD') - TARGET 670 (590) PENCE

----------

BARCLAYS RAISES VICTREX TO 'EQUAL WEIGHT' ('UNDERWEIGHT') - TARGET 1,980 (1,710) PENCE

----------

BARCLAYS CUTS SERCO GROUP PRICE TARGET TO 150 (165) PENCE - 'OVERWEIGHT'

----------

GOLDMAN RAISES BABCOCK INTERNATIONAL TARGET TO 290 (255) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES QUILTER PRICE TARGET TO 180 (170) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES JUPITER FUND PRICE TARGET TO 310 (300) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES ASHMORE GROUP PRICE TARGET TO 385 (360) PENCE - 'UNDERWEIGHT'

----------

JPMORGAN RAISES HOWDEN JOINERY GROUP TARGET TO 677 (641) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS SERCO GROUP PRICE TARGET TO 170 (180) PENCE - 'OVERWEIGHT'

----------

OTHER MAIN MARKET AND AIM

----------

BERENBERG RAISES CERES POWER PRICE TARGET TO 1220 (1060) PENCE - 'BUY'

----------

DEUTSCHE BANK RAISES STAGECOACH PRICE TARGET TO 86 (72) PENCE - 'BUY'

----------

BERENBERG CUTS PETRA DIAMONDS PRICE TARGET TO 2 (3) PENCE - 'HOLD'

----------

BERENBERG RAISES GRIFFIN MINING PRICE TARGET TO 115 (105) PENCE - 'BUY'

----------

BERENBERG RAISES GEM DIAMONDS PRICE TARGET TO 51 (43) PENCE - 'BUY'

----------

BERENBERG RAISES CENTRAL ASIA METALS PRICE TARGET TO 250 (234) PENCE - 'BUY'

----------

BERENBERG CUTS ANGLO PACIFIC GROUP PRICE TARGET TO 140 (150) PENCE - 'BUY'

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
Today 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
Today 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.